Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Aptuit

Aptuit is a pharmaceutical services company that delivers early to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Aptuit
Via Alessandro Fleming 4, 37135 Verona (VR), Italy
+39 045 8218111
Contact Aptuit
Website

 Latest Content from PMHub 

Blog the brand builder

White Papers and Resources | March 11, 2013 | Say Communications

This report looks into current practice in B2B marketing communications, the importance of online reputation, and the opportunities offered by social media. It confirms the move online and suggests that...

How to Master Multichannel Marketing in Pharma

White Papers and Resources | February 26, 2013 | Blue Latitude Health

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

Lucid: An Introduction

Videos and Podcasts | November 2, 2012 | Lucid Group Communications Limited

Lucid: A Guided Tour

Videos and Podcasts | November 2, 2012 | Lucid Group Communications Limited

Lucid: About Us

Videos and Podcasts | November 2, 2012 | Lucid Group Communications Limited

Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

Press Releases | May 30, 2011 | M3 (EU)

M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins as...